Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease

Manali Mukherjee, Parameswaran Nair

Source: Eur Respir Monogr 2022; 95: 219-237

Journal Issue: Eosinophilic Lung Diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Manali Mukherjee, Parameswaran Nair. Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease. Eur Respir Monogr 2022; 95: 219-237

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Eosinophils and eosinophilic immune dysfunction in health and disease Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021 Year: 2022
The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017
Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019
Eicosanoids and eosinophilic inflammation of airways in stable COPD. Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018
Inflammatory cell activation in eosinophilic and non-eosinophilic asthma Source: Annual Congress 2006 - Immunology of the airways Year: 2006
Cytokines profile in granulomatous lung disorders Source: Eur Respir J 2005; 26: Suppl. 49, 374s Year: 2005
Neutrophils in chronic inflammatory airway diseases: can we target them and how? Source: Eur Respir J 2010; 35: 467-469 Year: 2010
Biomarkers of eosinophilic inflammation Source: Eur Respir Monogr 2022; 95: 37-50 Year: 2022
Targeting TNF-alpha in inflammatory lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005
IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015
Characteristics of inflammatory bowel diseases-associated interstitial lung diseases Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020 Year: 2020